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’INTRODUCTION
Tyrosine phenol-lyase (TPL; E.C. 4.1.99.2) is a pyridoxal 50-
phosphate (PLP)-dependent enzyme, which catalyzes the rever-
sible cleavage of the Cβ Cγ bond of L-Tyr to produce phenol,
ammonium, and pyruvate (Scheme 1). In addition to its physio-
logical reaction, in vitro TPL catalyzes a plethora of other
reactions including β-elimination (and its reversal) of a number
of other α-amino acids and several structurally similar compounds,
1
as well as β-substitutions by phenol derivatives and their hetero-
cyclic analogues.
2 Some of these TPL-catalyzed reactions have
been utilized for biotechnological production of L-Tyr and several
related compounds like L-DOPA, a top-selling drug prescribed
for treatment of Parkinson’s disease.
3 In addition, TPL was
modiﬁed by mutagenesis to have better performance in speciﬁc
nonphysiological catalytic tasks, which proved to be useful for
“green” organic synthesis of L-Tyr derivatives, including several
pharmaceuticals and their precursors.
4
The phenolic moiety is not a good leaving group, so its
elimination from L-Tyr is a mechanistically intriguing process.
5
The postulated mechanism,catalyzedbyTPL,consists ofseveral
intermediate steps (Scheme 1): (a) formation of the external
aldimine by the reaction of the internal aldimine and L-Tyr; (b)
Cα-proton abstraction performed by the PLP-binding Lys257
(amino acid numbering is for Citrobacter freundii TPL) resulting
in the quinonoid intermediate; and (c) protonation of the
substrate’sC γ atom by Tyr71 of the adjacent subunit and the
concerted elimination of phenol along with the formation of
α-aminoacrylate.
6 We note that Scheme 1 shows protonation of
CγandCβ Cγbondcleavageasoccurringinastepwisemechanism;
however, multiple isotope eﬀects on the reaction of tryptophan
indole-lyase, a structurally and mechanistically very similar enzyme,
suggest a mechanism with concerted protonation and
elimination.
7
TPLisa homotetramer with four active sites,two per catalytic
dimer, located at the monomer monomer interface.
8,9 Rearran-
gementofthelargeandsmalldomainsinaTPLsubunitresultsin
two diﬀerent active-site conformations: open and closed.
10,11
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ABSTRACT: The key step in the enzymatic reaction catalyzed
by tyrosine phenol-lyase (TPL) is reversible cleavage of the
Cβ Cγ bond of L-tyrosine. Here, we present X-ray structures
for two enzymatic states that form just before and after the
cleavage of the carbon carbon bond. As for most other
pyridoxal 50-phosphate-dependent enzymes, the ﬁrst state, a
quinonoidintermediate,iscentralforthecatalysis.Wecaptured
this relatively unstable intermediate in the crystalline state by
introducingsubstitutionsY71F orF448HinCitrobacterfreundii
TPL and brieﬂy soaking crystals of the mutant enzymes with a substrate 3-ﬂuoro-L-tyrosine followed by ﬂash-cooling. The X-ray
structures, determined at ∼2.0 Å resolution, reveal two quinonoid geometries: “relaxed” in the open and “tense” in the closed state
oftheactivesite.The“tense”stateischaracterizedbychangesinenzymecontactsmadewiththesubstrate’sphenolicmoiety,which
result in signiﬁcantly strained conformation at Cβ and Cγ positions. We also captured, at 2.25 Å resolution, the X-ray structure for
the state just after the substrate’sC β Cγ bond cleavage by preparing the ternary complex between TPL, alanine quinonoid and
pyridine N-oxide, which mimics the α-aminoacrylate intermediate with bound phenol. In this state, the enzyme ligand contacts
remain almost exactly the same as in the “tense” quinonoid, indicating that the strain induced by the closure of the active site
facilitateseliminationofphenol.Takentogether,structuralobservationsdemonstratethattheenzymeservesnotonlytostabilizethe
transition state but also to destabilize the ground state.16469 dx.doi.org/10.1021/ja203361g |J. Am. Chem. Soc. 2011, 133, 16468–16476
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A quinonoid species is the key intermediate in almost all
reactions catalyzed by PLP-dependent enzymes,
12,13 but due to
its low stability, there are only a few reports on structures of this
important intermediate.
11,14 Recently, we reported X-ray struc-
tures for TPL quinonoid intermediates prepared by soaking holo-
enzyme crystals with inhibitors L-Ala and L-Met.
11 While in the
crystals of holoenzyme both subunits of the asymmetric part
were in the “open” state, in the crystals of quinonoid intermedi-
ates one of the two subunits adopted the closed conformation.
Twolines ofevidenceindicatedthatdiﬀerences betweenthetwo
states were not induced by lattice forces aﬀecting the individual
subunits in the crystal. First, spectroscopic measurements in-
dicated equivalence of complexes formedin crystalto complexes
formed in solution.
15 Second, the two states, open and closed,
were earlier observed in the structure of apoenzyme, which did
not involve soaking, suggesting that the two states represent two
energeticallyfavorablestates.Furthermore,achangingpatternof
molecular contacts observed in crystals for diﬀerent states demon-
strated plasticity in molecular interactions, suggesting that do-
main movements were not restricted by crystal contacts. Taken
together, these observations indicated that structures of TPL com-
plexes in crystallo were directly related to complexes that form in
solution.
Despite previous structural data, the molecular mechanism of
the reaction and in particular the detailed structural changes
accompanying and facilitating the cleavage of the Cβ Cγ bond
of the physiological substrate L-Tyr and the subsequent elimina-
tionofphenolremainedelusive.Herein,weshowthattheclosure
of TPL active site does not only bring the catalytically important
Thr124 and Arg381 into positions suitable for catalysis, but also
causes a signiﬁcant strain in the quinonoid intermediate formed
with the substrate. The resulting “tense” quinonoid intermediate
is less stable and thus more liable to the cleavage of the Cβ Cγ
bondintheﬁnalstageoftheβ-elimination.Thesenotionsarebased
on the crystal structures of the quinonoid intermediates formed
with the substrate 3-ﬂuoro-L-tyrosine (3-F-L-Tyr; Chart 1).
3-F-L-Tyr was used for preparation of quinonoid intermediates
becauseitskineticpropertiesareverysimilarto L-Tyr,
16 18butit
is at least 5 times more soluble in the solution used for pre-
paration of complexes (see the Experimental Section). The
quinonoid intermediates were “captured” in the crystalline state
of C. freundii TPL by introducing replacements Y71F or F448H.
Thesemutant enzymeslack the β-elimination activitywith L-Tyr
or 3-F-L-Tyr as a substrate; instead, they accumulate quinonoid
intermediates when incubated in the solution of either of these
two amino acids.
15 17 We used this property to prepare crystals
of quinonoid complexes. Soaking crystals of the Y71F or F448H
mutant holoenzymes with 3-F-L-Tyr for about 15 s resulted in a
quick color change, from yellow to orange, suggesting formation
of the quinonoid intermediate. However, unlike for quinonoid
complexes formed with L-Ala and L-Met,
11 diﬀraction quality of
these crystals deteriorated very rapidly, necessitating short soak-
ing times followed by ﬂash-cooling in liquid nitrogen. The
structures, determined at 2.04 Å (Y71F) and 2.00 Å (F448H)
resolution, reveal two diﬀerent geometries of the quinonoid
intermediate:“relaxed”intheopenand“tense”intheclosedcon-
formation of the active site. In addition, we determined the
structure of the wild-type TPL in complex with alanine quino-
noid and pyridine N-oxide. This structure mimics the state just
after theCβ Cγbond cleavage,withthe α-aminoacrylate inter-
mediate and a phenol molecule bound in the closed active site.
’RESULTS AND DISCUSSION
Quinonoid Intermediate in the Open Active Site of Y71F
TPL. The crystalline quinonoid intermediate of Y71F TPL
formed with 3-F-L-Tyr has two crystallographically independent
activesitesinthesamecatalyticdimer.Oneactivesiteofthis2.04
Å resolution structure is found in the open conformation. It is
occupied by the 3-F-Tyr quinonoid (λmax = 502 nm in crystal)
15
formed after the Cα-proton abstraction from the external
aldimine of 3-F-L-Tyr (Figure 1a; Chart 2). The corresponding
quinonoid geometry is characterized by the sp
2-hybridized Cα
and Cγ atoms, each in a trigonal planar environment, and the
phenolic moiety rotated with respect to the Cα Cβ bond
(torsion angle Cα Cβ Cγ Cδ1) by 73  (Figure S1 in the
Supporting Information). All H-bonds and salt bridges with the
enzyme observed for the quinonoid intermediates formed with
L-Ala or L-Met
11 are also found in the open active site of the 3-F-
Tyr quinonoid (Figure 1a). Additionally, the hydroxyl group of
the 3-F-Tyr quinonoid complex forms H-bonds with two water
molecules, while the fluorine atom is H-bonded to only one of
them.Thesubstrate’shydroxylisatthedistanceof4.1Åfromthe
hydroxyl of Thr124 and at 4.8 Å from the closest nitrogen atom
in the guanidine of Arg381. Because in this open conformation
there is no strain on the quinonoid molecule induced by the
enzyme, we refer to this quinonoid geometry as the “relaxed” state.
Quinonoid Intermediate of F448H TPL. The 2.0 Å resolu-
tionstructureofF448HTPLcomplexedwith3-F-L-Tyrcontains
fourcrystallographicallyindependentactivesites,allfoundinthe
closed conformation (Figures 1b and S4 S7). It was shown by
rapid-scanning stopped-flow spectroscopy that F448H TPL
accumulates the quinonoid intermediate (λmax = 515 nm) when
Scheme 1. β-Elimination Reaction of L-Tyr Catalyzed by
TPL
Chart 1. 3-Fluoro-L-tyrosine16470 dx.doi.org/10.1021/ja203361g |J. Am. Chem. Soc. 2011, 133, 16468–16476
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incubated with 3-F-L-Tyr.
17 We note, however, that the quino-
noidintermediatecan bemodeledintheF448HTPL active sites
only in a “tense” (strained) geometry with the Cα Cβ Cγ
angle of 103 106  (in contrast to 109  in the “relaxed” state)
and the Cγ atom in a pyramidal geometry with the correspond-
ing pyramidalization angle of 18 23  (Figure 2a; Table 1).
Becausetheestimatedcoordinateerrorforthisstructurewas0.15Å,
20
such distorted geometry was validated using several approaches.
First, we noted that the structure of the “tense” quinonoid could
be refined satisfactorily only when the planarity restraints at the
Cγ atom were released (Figure 2b). In contrast, refinement with
the standard geometrical restraints keeping the Cγ atom in a
planar environment reduced fit into electron density maps
(FiguresS3andS11intheSupportingInformation)andresulted
Figure 1. Quinonoid intermediates of the Cβ Cγ bond cleavage trapped in crystal structures (stereo views). The σA-weighted |Fo|   |Fc| omit
electrondensitymapscontouredat3.0σareinblue.Residuesfromthelargedomainarecoloredinorange,thosefromthesmalldomainareinpink,and
residues from the adjacent subunit are depicted in blue and labeled with an asterisk. Hydrogen bonds are denoted by dashed lines. (a) Open active site
(B) of Y71F TPL with the “relaxed” 3-F-Tyr quinonoid. (b) One of the four closed active sites of F448H TPL with the “tense” 3-F-Tyr quinonoid.
(c)Thedisorderedactivesite(A)ofY71FTPLoccupiedmostlybythe“tense”(gray;0.67occupancy)andpartiallybythe“relaxed”3-F-Tyrquinonoid
(yellow;0.33occupancy).Onlytheclosedactive-siteconformationcouldbemodeled;agreenhashedcylinderindicatesaclosecontactbetweenPhe448
and the “tense” quinonoid.16471 dx.doi.org/10.1021/ja203361g |J. Am. Chem. Soc. 2011, 133, 16468–16476
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in the reduction of the tetrahedral Cα Cβ Cγ angle to 90 96 
(depending on a particular subunit) from 109  observed in the
“relaxed” quinonoid state. Such significant reduction is highly
improbable,andindeedthePh CH2 Canglesoflessthan105 
have notbeen observed in smallmolecule structures.
21 Although
absorption spectra obtained in solution
17 did not indicate for-
mationofthealternative,externalaldimineintermediate,wehave
attempted modeling and refining this intermediate (Figures S9
and S11). Refinement with the standard geometrical restraints
resulted in external aldimine models with multiple geometrical
distortions: the Cα Cβ Cγ angles of 102 106 , a slight
pyramidalization of Cγ (2 4 ), flattening of a tetrahedral Cα
(a chiral volume of 2.1 2.2 Å
3 in comparison with 2.5 Å
3 in
L-Tyr),andtheN C40 C4 C3 torsion angles of 23 27 .Th e s e
observationsindicatedthattheclosedactivesitesdidnotcontain
the external aldimine intermediate, in agreement with spectro-
scopic data.
17 The final models were further validated using
severalcomputationalapproachesasdetailedintheExperimental
Section.
Distortionofthebenzenemoiety(includingbondlengthalter-
nations and out-of-plane deformations) is a well-known phe-
nomenon observed in sterically constrained aromatic molecules
(duetothebulkysubstituentsorthecrystal-packinginteractions).
22
DFT calculations in the gas phase showed that the “tense”
molecule of 3-F-Tyr quinonoid is by 12 21 kcal mol
 1 less
favorable than the “relaxed” form. However, closure of the active
site results in a signiﬁcant increase in the number of enzyme 
quinonoid contacts (as described in the next paragraph), which
might compensate for the observed distortion and thus stabilize
the quinonoid molecule in the “tense” geometry. It is important
to note that the “tense” quinonoid molecule appears to be the
species “prepared” for the attack of a proton at the Cγ atom and
consecutive Cβ Cγ bond cleavage. The phenol elimination
should proceed through the transition structure with (at least) a
partially sp
3-hybridized Cγ atom, similar to the ketoquinonoid
structureshowninScheme1.Inagreementwiththis,theproton-
donating hydroxyl group of Tyr71 is in a suitable position
(Figure1b), being atadistance of3.8 3.9Åinfour crystallogra-
phically independent subunits from the Cγ atom of the quinonoid.
Quinonoid Intermediate in the Closed Active Site of Y71F
TPL. The second subunit of the catalytic dimer in the Y71F TPL
complex is statistically disordered (details provided in the Sup-
portingInformation),butitisfoundpredominantlyintheclosed
conformation(Figure1c).LikeinthecaseofF448HTPL,theclosed
active-site state of Y71F TPL is occupied by the quinonoid
moleculeinthe“tense”conformation,withtheCα Cβ Cγangle
of108 andtheCγpyramidalizationangleof27 (Figure3;Table1).
Chart 2. Quinonoid Intermediate with 3-Fluoro-L-tyrosine
with the Corresponding Atom-Numbering Scheme
Table 1. Key Angles in the Quinonoid Structures (deg)
structure: Y71F TPL 3-F-L-Tyr F448H TPL 3-F-L-Tyr
conformation: “relaxed”“ tense”“ tense”
active site: A B A A B C D
Cα Cβ Cγ 105 109 108 106 105 104 103
Cα Cβ Cγ Cδ1 (torsion angle)
a 77 73 77 81 83 80 81
pyramidalization angle at Cγ
b 0 . 62 2 7 1 82 32 02 0
aCα Cβ Cγ Cδ1referstothetorsionangledeﬁningrotationaroundtheCβ Cγbond.
bPyramidalizationangleatCγ,deﬁnedasananglebetween
the Cβ Cγ line and the Cδ1 Cγ Cδ2 plane, was calculated using PLATON.
19
Figure 2. (a) Geometry of a 3-F-Tyr quinonoid molecule in the “tense” conformation observed in the closed active sites of F448H and Y71F TPL.
(b)A stereo view of a 3-F-L-Tyr quinonoidin a closedactive site of F448H reﬁnedusing the standard (yellow) andrelaxed (gray) geometrical restraints.
Theundistortedquinonoidgeometry(thinblacklines)isshownforcomparison.TheσA-weighted|Fo| |Fc|omitelectrondensitymapisshownat3.0σ.16472 dx.doi.org/10.1021/ja203361g |J. Am. Chem. Soc. 2011, 133, 16468–16476
Journal of the American Chemical Society ARTICLE
In the case of Y71F TPL, spectra were previously measured both
in solution
16 and in crystallo,
15 revealing formation of the quinonoid
intermediate upon addition of 3-F-L-Tyr and ruling out the
existence of the external aldimine. Significantly, spectra obtained
in crystallo were essentially identical to those recorded from
solution. In agreement with spectroscopic observations, refine-
mentoftheexternalaldimineintermediateresultsinahighlydis-
torted structure(FiguresS8 and S10 intheSupporting Information),
Figure 3. Ligands modeled in the disordered active site of Y71F TPL. A stereo view with the “relaxed” (yellow) and “tense” (gray) quinonoid
molecules superimposed with the corresponding σA-weighted |Fo|   |Fc| omit electron density maps contoured at 3.0σ.
Figure 4. Stereo view of the closed active site of the wild-type TPL with bound PNO. The σA-weighted |Fo|   |Fc| omit electron density maps are
contoured at 3.0σ. Residues are colored as in Figure 1. Hydrogen bonds are denoted by dashed lines. The alanine quinonoid, the phosphate anion, and
the Wat2 solvent molecule were modeled with 0.5 occupancy.
Figure 5. Protein substrate interactions during the three intermediate steps of the Cβ Cγ bond cleavage observed in crystal structures. Hydrogen
bonds are shown as dashed lines. A short van der Waals contact between the side chain of Phe448 and the substrate phenolic group is denoted by a
hashed line. Label colors correspond to residue colors in Figure 1.16473 dx.doi.org/10.1021/ja203361g |J. Am. Chem. Soc. 2011, 133, 16468–16476
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like in the case of F448H TPL. These observations further support
the model with the “tense” quinonoid in the closed active site.
AllH-bondingandsalt-bridgecontactswiththeenzymefound
in the “relaxed” conformation of the Y71F TPL complex are also
present in the “tense” conformation of the 3-F-Tyr quinonoid
(Figure 1). However, the “tense” conformation is additionally sta-
bilized by H-bonds formed between the substrate’s hydroxyl
groupand the hydroxyl group of Thr124 as well as the guanidine
group of Arg381. The phenyl ring and the hydroxyl group of the
substrateintheclosedactivesiteoftheY71FTPLcomplexarein
close contacts with the side chain of Phe448 (the shortest
distanceis3.1Å).Thesestructuralobservationsarecorroborated
by the earlier biochemical studies, which showed that both Thr124
and Phe448 are required for substrate speciﬁcity of TPL,
17 while
the deprotonated side chain of Arg381 has an unusual role as a
catalytic base (Scheme 1).
9 In both open and closed conforma-
tions,Arg381ispartofatriadofH-bondedresiduesinvolvingthe
guanidineofArg381,thehydroxylofSer385,andthecarboxylate
of Glu380 (Figures 5 and S13). Via this H-bond network, the
negativelychargedcarboxylateofGlu380couldadditionallyactivate
Arg381 to act as the catalytic base. In the F448H TPL complex,
the substrate’s phenolic group is not only H-bonded to the side
chains of Arg381 and Thr124, but also to the imidazole group of
His448(mutatedPhe448).TheadditionalH-bondfurtherstabilizes
Table 2. Crystallographic Data Processing and Reﬁnement Statistics
structure Y71F TPL 3-F-L-Tyr F448H TPL 3-F-L-Tyr TPL L-Ala PNO
Data Collection and Processing
space group P21212 P212121 P21212
unit cell parameters
a (Å) 133.6 136.4 134.0
b (Å) 144.4 143.8 143.8
c (Å) 59.7 118.5 60.1
radiation source ESRF BM14 ESRF BM30A Rigaku Ru200 with rotating anode (Cu-Kα)
wavelength (Å) 0.980 0.980 1.5418
resolution range
a (Å) 17.0 2.04 (2.09 2.04) 30.0 2.00 (2.07 2.00) 20.0 2.25 (2.29 2.25)
unique reﬂections 71319 (4260) 154478 (13859) 55230 (2668)
Rmerge (%) 4.6 (34.6) 9.1 (53.1) 4.8 (17.2)
average I/σ(I) 13.7 (3.2) 7.5 (2.5) 13.8 (4.5)
redundancy 3.0 (1.9) 4.7 (4.5) 3.4 (2.8)
completeness (%) 96.5 (83.6) 99.0 (99.2) 98.8 (94.3)
Wilson B-factor (Å
2) 28.2 22.4 34.6
Reﬁnement and Model Correlation
no. of atoms
protein 7 306 14634 7281
ligand 80 393 101
solvent 745 1863 791
reﬂections used in reﬁnement 70272 (4193) 152931 (13724) 54235 (2623)
Rcryst (%) 16.3 (20.1) 14.1 (17.8) 13.9 (17.0)
Rfree (%) 20.9 (23.3) 17.5 (22.9) 18.1 (22.9)
reﬂections used for Rfree 1047 (69) 1547 (135) 995 (45)
average B-factor (Å
2)
polypeptide chain A/B/C/D 38.9/34.7/ /  22.3/24.1/22.4/23.2 29.8/28.4/ / 
ligand 27.2 18.1 18.9
solvent 26.6 29.0 26.3
overall 36.8 23.9 28.9
deviations from ideal geometry
b
bond lengths (Å) 0.014 (0.022) 0.013 (0.022) 0.014 (0.022)
bond angles (deg) 1.4 (2.0) 1.3 (2.0) 1.3 (2.0)
estimated coordinate error
c (Å) 0.15 0.12 0.16
Ramachandran plot
d (%)
favored 97.6 97.8 98.1
outliers 0.0 0.2
e 0.0
PDB accession code 2ycn 2ycp 2yct
aValues in parentheses are for the outer resolution shell.
bTarget values are given in parentheses.
cThe diﬀraction-component precision index (DPI)
based on Rfree.
19 dAnalyzed by MolProbity.
39 eThe only Ramachandran plot outliers are Met121(A), Met121(B), and Met121(C) with the j and ψ
values next to the borderline of the allowed region
45 and very similar to those of Met121(D). All of these residues are clearly deﬁned in the electron
density maps.16474 dx.doi.org/10.1021/ja203361g |J. Am. Chem. Soc. 2011, 133, 16468–16476
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theclosedconformationandthuspreventsthecompletionofthe
enzymatic reaction. This explains why F448H TPL exhibits very
low β-elimination activity with L-Tyr, but retains signiﬁcant
activity toward the substrates with good leaving groups, which
cannot form H-bonds with His448 in the mutated enzyme.
17 In
the wild-type TPL, the phenyl group of Phe448 induces further
strain on the substrate as evidenced by the larger Cγ pyramida-
lization angle in the closed active site of the Y71F TPL complex.
TPL Complexwith Alanineand Pyridine N-Oxide.Previous
spectroscopic
23,24 and crystallographic
11 studies showed that
wild-type TPL forms the Ala quinonoid intermediate when in-
cubated with L-Ala. Pyridine N-oxide (PNO) binds selectively to
the Ala quinonoid intermediate.
24 We used this knowledge to
prepare the ternary complex by soaking the wild-type holo-TPL
crystals with a mixture of L-Ala and PNO. The structure of this
complex, determined at 2.25 Å resolution, mimics the α-ami-
noacrylate intermediate with the phenol molecule bound in the
activesite(Scheme1).Whiletheopenactivesiteofthisstructure
is occupied only by the internal aldimine, the closed active site
contains a mixture of different ligands in a statistical disorder
(details provided in the Supporting Information; Figure 4). A
PNO molecule is bound in the pocket of the closed active site
otherwise occupied by the substrate’s phenolic moiety in Y71F
and F448H TPL complexes. The C4 atom of the PNO molecule
(theequivalentofCγin L-Tyr)islocatedonly3.0ÅfromtheCβ
of the Ala quinonoid, so this structure models a phenol molecule
and the α-aminoacrylate intermediate just after the cleavage of
thesubstrate’sCβ Cγbond.MeanplanesofthePNOmolecule
and the “alanine” moiety (atoms Cα,C β, imino N, and carboxylic
C) inthequinonoidmakeanangleofonly26 (Figure4).Wenote
that the equivalent angle in the “relaxed” quinonoid molecule is
110 , in contrast to 78  found for the “tense” quinonoid in the
Y71F TPL complex and 81 84  observed for the F448H TPL
complex. Like in the “tense” quinonoid, the O atom of the PNO
makes H-bonds with the side chains of Thr124 and Arg381, with
a close contact (∼2.9 Å) being made between the C4 atom of
PNO and the proton-donating hydroxyl of Tyr71. The close
resemblance of enzyme ligand contacts in the “tense” quino-
noid to contacts observed in this complex, representing the state
just after the Cβ Cγ bond cleavage, indicates that the strained
conformation induced by the closure of the active site facilitates
elimination of phenol.
After completion of the β-elimination reaction, the active site
has to open to release the phenol molecule. As the closed con-
formationoftheactivesite andaboundphenolmoleculeprotect
the α-aminoacrylate intermediate from the solvent, we speculate
that the α-aminoacrylate intermediate can undergo the transal-
dimination reaction only after a phenol molecule is released and
the active site becomes solvent accessible. In that way, the other
product of this reaction, an iminopyruvate molecule, can be
released and become available for the nonenzymatic hydrolysis
(Scheme 1).
The bonds being broken as the result of the catalytic act are
oriented trans (anti) to each other on opposite sides of the PLP
plane. Thus, the mechanism that is operative in the case of TPL
should be classiﬁed as anti-E1cb. Until now, this anti elimination
was reported only in the case of O-acetylserine sulfhydrylase
25
where the concerted E2 mechanism was observed. The data
indicate, therefore, that the traditional notion that most PLP-
dependent enzymes catalyze their elimination reactions via an
E1cb mechanism with syn-geometry
12 is somewhat exaggerated.
It is noteworthy that in many cases the transfer of the hydrogen
isotope label from the α-position of the substrate to the leaving
group is considered to be the strongest argument for this mechan-
ism. However, the internal return may be associated with the
concomitant isotopic exchange reaction, especially under the
conditions where a single turnover in the main elimination reaction
corresponds to several turnovers in the exchange reaction.
’CONCLUSION
Taken together, the presented structures demonstrate the im-
portanceoftheclosedconformationfortheenzymaticactivity of
TPL. It is evident that the closure of the active site induces a
signiﬁcant strain in the quinonoid intermediate, facilitating dis-
tortion of the substrate’sC α Cβ Cγ angle and pyramidaliza-
tionoftheCγatom.Structuralobservationsindicatethatthe“tense”
structure is stabilized by the H-bonds between the substrate’s
phenol hydroxyl and Arg381 and Thr124, as well as van der
WaalscontactswithPhe448 (Figure5).Torelease thestrain,the
“tense”quinonoidismoresusceptibletotheCγ-protonationand
the Cβ Cγ bond cleavage, which ultimately result in the
elimination of phenol. Thus, the closure of the active site serves
as the main driving force for the β-elimination reaction of L-Tyr.
The remarkable rate accelerations seen in enzyme catalysis
have been often attributed primarily to transition-state stabiliza-
tion,aswasﬁrstproposedbyPauling.
26However,ithasbeensug-
gested that ground-state destabilization may contribute as much
or even more to the decrease in activation energy as transition-
state stabilization.
27 In fact, on the basis of the structure of hen
egg white lysozyme, the ﬁrst enzyme crystal structure to be ob-
tained,itwasproposedthatthereactiveD-ringofthesubstrateis
forced to adopt a higher energy half-chair conformation on
binding, introducing strain that would be relieved on formation
of the oxocarbenium ion intermediate.
27 Evidence for electronic
strainofπ-bondsinboundsubstrateswasobtainedbyvibrational
spectroscopy by Carey for thiol proteases,
28 by Belasco and
Knowles with triose phosphate isomerase,
29 and more recently
by Anderson for enoyl-CoA hydratase.
30 Evidence for ground-
state strain was very recently obtained by Zhang and Schramm
from examination of equilibrium isotope eﬀects on binding of
substrates to orotate phosphoribosyltransferase.
31 However, there
appear to be no crystal structures that have shown a clear evidence
for substrate strain. The results of the present crystallographic
study demonstrate that TPL induces signiﬁcant strain in the
quinonoid complex of the substrate, distorting it in the ground
state toward the transition state geometry required for cleavage
of the formally unactivated Cβ Cγ bond.
’EXPERIMENTAL SECTION
Preparation of Quinonoid Complexes. Wild-type, Y71F, and
F448H C. freundii TPL were produced in Escherichia coli SVS 370 cells
transformed with the plasmid pTZTPL containing either the wild-type
or the mutant TPLgene.Allproteins were purifiedasdescribedbefore.
17,18
Crystals of the wild-type and mutant holo-TPL were grown using pre-
viously established conditions.
10,11,15 The alanine quinonoid complex
with pyridine N-oxide (PNO) was prepared by soaking wild-type TPL
crystalsinthestabilizationsolutioncontaining40%(w/v)poly(ethylene
glycol) 5000 monomethyl ether (PEG 5000 MME), 50 mM triethano-
lamine pH 8.0, 0.25 M KCl, 0.2 mM PLP, 0.5 mM dithiothreitol, with
addition of 100 mM L-Ala and a saturating concentration of PNO.
Becausethecrystals’qualitydeterioratedrapidly,thesoakingtimehadto
be restricted to ∼20 s. Complexes of the mutant TPL proteins with the
substrate 3-fluoro-L-tyrosine (3-F-L-Tyr) were prepared by soaking16475 dx.doi.org/10.1021/ja203361g |J. Am. Chem. Soc. 2011, 133, 16468–16476
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crystals in the same stabilizing solution but with addition of10 mM 3-F-
L-Tyr.Topreventcrystaldeterioration,soakingtimehadtoberestricted
to ∼30 s.
Structure Determination and Analysis. All crystals were flash-
cooled in liquid nitrogen directly from the soaking conditions. Diffrac-
tion data were collected at 100 K and processed using DENZO and
SCALEPACK,
32 Table 2. Most crystallographic calculations were car-
riedoutusingtheCCP4programpackage.
33ThestructureoftheF448H
TPL 3-F-L-Tyr was determined by molecular replacement (PHASER)
34
usingthecompletetetrameroftheC.freundiiTPLapoenzyme(PDBID:
2ez2)
10 as a search model. All other structures were refined using the
TPL apoenzyme dimer as a starting model (PDB ID: 2ez2).
10 Models
were rebuilt by COOT,
35 and water molecules were added using ARP/
wARP.
36 The refinement was performed by REFMAC
37 with the small
(residues19 44,346 404,434 456)andlarge(residues1 13,45 345,
405 422) domains
10 of each subunit treated as separate TLS groups.
38
Models of ligand molecules were generated by SKETCHER, and the cor-
responding library files for the refinement were created by LIBCHECK.
33
The final refined models were further validated using MolProbity.
39
Geometries of the 3-F-Tyr quinonoid molecules were cross-checked
using the MAESTRO program suite.
40 The initial model of the 3-F-Tyr
quinonoid molecule was optimized by molecular mechanics using the
all-atom OPLS force field in MACROMODEL.
41 The optimized ligand
model was docked into the active sites and refined in real space against
the corresponding omit σA-weighted |Fo|   |Fc| electron density maps
using program PRIMEX.
42 The all-atom OPLS force field, the default
electrondensityweights(120forenergyand50forscoring),andthelow
planar group restraints were used throughout the refinement in PRI-
MEX. DFT calculations on the quinonoid models refined in PRIMEX
were performed with GAMESS
43 at the B3LYP level, using the 6-31G(d)
basis set in the gas phase. Figures were made by PyMOL.
44
’ASSOCIATED CONTENT
b S Supporting Information. Detailed description of X-ray
structures and stereo views of ligand models superimposed with
theelectrondensitymaps.Thismaterialisavailablefreeofcharge
via the Internet at http://pubs.acs.org.
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